These outcomes imply that higher levels of p-AMPK and pro-Casp8 inactivated the necroptosis pathway-associated proteins (RIPK3 and p-MLKL) in PACs during caerulein-induced AP development. The gene discussed is RIPK3; the disease is alkaline phosphatase measurement.